Histocyte Laboratories provide technology for producing cells whice are consistent, robust and provide reproducible results. This know-how has been applied to breast cancer for Her2, ER and PR, as well as ALK translocation in lymphoma (NPM-ALK) and lung cancer (EML4-ALK).  Lastly, for HPV ISH (DNA and mRNA) and p16 IHC. Working with the histopathology field we are extending claims for these products and are planning on launching more novel controls in the near future.